Because I practice pharmaceutical injury law nationwide, I’ve been very interested in the debate over “innovator liability” in Alabama. That’s the name for the legal theory the Alabama Supreme Court…
Read More
As a pharmaceutical liability lawyer, I’ve written several posts here recently about generic Reglan lawsuits. Generic versions of Reglan, a drug for gastroesophageal reflux disease, have been the subjects of…
Read More
Pfizer, the makers of the acid reflux drug Reglan, filed a rehearing request on February 19 that is asking the Alabama Supreme Court to reconsider one of its recent rulings…
Read More
According to recent reports, the acid reflux drug Reglan is now facing new restrictions in Europe because of the drug’s link to neurological disorders like tardive dyskinesia. These new restrictions…
Read More
As a U.S. Supreme Court generic Reglan lawsuit case has finally seen the inside of a courtroom, many people are expecting the ruling will change the entire way that pharmaceutical…
Read More
In the past few years, the U.S. Supreme Court has made life even tougher for victims of injuries caused by generic prescription drugs. In PLIVA v. Mensing, the Court barred…
Read More
Hospira, the manufacturers of a generic version of the acid reflux drug Reglan, has issued a recall of the pills after it was discovered that the drug contained strands of…
Read More
Last week, I wrote as a pharmaceutical liability lawyer about a generic Reglan injury lawsuit at the U.S. Supreme Court, which closed another legal avenue of recovery against drug manufacturers.…
Read More
I’ve written much on this blog about the terrible consequences of the U.S. Supreme Court’s ruling in PLIVA v. Mensing. In that case, the Court found that victims of injuries…
Read More
Last month, I wrote here as a dangerous drug lawyer about an Eighth U.S. Circuit Court of Appeals decision involving claims against generic and name-brand Reglan makers. In Bell v.…
Read More